Population pharmacokinetic analysis during the first 2 years of life: an overview. (Q38062388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Population pharmacokinetic analysis during the first 2 years of life: an overview (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Amélie Marsot

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Audrey Boulamery

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Bernard Bruguerolle

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

787-798

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

Testing medications in children.

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

The ethics of clinical trials: a child's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Off label and unlicensed drug use among French office based paediatricians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Optimizing pediatric dosing: a developmental pharmacologic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

My child is unique; the pharmacokinetics are universal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Facilitation of drug evaluation in children by population methods and modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

The population pharmacokinetics of theophylline in neonates and young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of vancomycin in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Haemodynamic responses and population pharmacokinetics of midazolam following administration to ventilated, preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of intravenous amoxicillin in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Tobramycin population pharmacokinetics in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of caffeine in premature neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of vancomycin in Japanese pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

The kinetic profile of vancomycin in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation: midazolam neonatal pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

The pharmacokinetics of theophylline in premature neonates during the first few days after birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Pharmacokinetics and dose requirements of vancomycin in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Pharmacokinetics of zidovudine in infants: a population analysis across studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Vancomycin population pharmacokinetics in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Caudal ropivacaine in infants: population pharmacokinetics and plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of panipenem in neonates and retrospective evaluation of dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population kinetics of tobramycin in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

The influences of renal function and maturation on vancomycin elimination in newborns and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

NONMEM and NPEM2 population modeling: a comparison using tobramycin data in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of cisapride in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of gentamicin in South African newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of ibuprofen enantiomers in very premature neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Pharmacokinetics of levobupivacaine after caudal epidural administration in infants less than 3 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of cefepime in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetic investigation of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of amphotericin B lipid complex in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of gentamicin in premature newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Application of routine monitoring data for determination of the population pharmacokinetics and enteral bioavailability of phenytoin in neonates and infants with seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of allopurinol in full-term neonates with perinatal asphyxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Inter-individual variability in propofol pharmacokinetics in preterm and term neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetic investigation of digoxin in Japanese neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics and dosing regimen design of milrinone in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

I.V. acetaminophen pharmacokinetics in neonates after multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of cefepime in neonates with severe nosocomial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of fluconazole in young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of domperidone in preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of ketorolac in neonates and young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Meropenem pharmacokinetics in the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population pharmacokinetics of micafungin in neonates and young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Clonidine clearance matures rapidly during the early postnatal period: a population pharmacokinetic analysis in newborns with neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population Pharmacokinetics of Nevirapine in HIV-1-Infected Pregnant Women and Their Neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Population clinical pharmacology of children: modelling covariate effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

The fourth dimension of life: fractal geometry and allometric scaling of organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Mechanistic basis of using body size and maturation to predict clearance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Human renal function maturation: a quantitative description using weight and postmenstrual age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Clinical pharmacokinetics of sedatives in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

Pharmacokinetics of antiepileptic drugs

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS40262-012-0015-8

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Clinical pharmacokinetics in infants and children. A reappraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Neonatal seizures and their treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics of ceftizoxime in premature newborns

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics of midazolam in neonates.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population kinetics of gentamicin in neonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics of gentamicin in premature infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics of gentamicin in neonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics of caffeine in neonates and young infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed-effects model

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Vancomycin pharmacokinetics in infants: relationships to indices of maturation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

Population pharmacokinetics of rectal theophylline in neonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179579

12 December 2020

10.1007/S40262-012-0015-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

18 February 2020

1030633347

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179579%20AND%20SRC:MED&resulttype=core&format=json